Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001104659-21-022191
Filing Date
2021-02-16
Accepted
2021-02-12 18:02:59
Documents
2
Group Members
RICHARD AMMER, M.D., PH.D.

Document Format Files

Seq Description Document Type Size
1 SC 13D tm216164d1_sc13d.htm SC 13D 82690
2 EXHIBIT 99.1 tm216164d1_ex99-1.htm EX-99.1 4615
  Complete submission text file 0001104659-21-022191.txt   88898
Mailing Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103
Business Address TWO LOGAN SQUARE 100 N. 18TH STREET, SUITE 300 PHILADELPHIA PA 19103 (267) 207-3606
Vallon Pharmaceuticals, Inc. (Subject) CIK: 0001824293 (see all company filings)

EIN.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92206 | Film No.: 21630495
SIC: 2834 Pharmaceutical Preparations

Mailing Address SANKT-JACOBS-STRASSE 90 CH-9002 BASEL V8 4052
Business Address SANKT-JACOBS-STRASSE 90 CH-9002 BASEL V8 4052 61 3137965
SALMON Pharma GmbH (Filed by) CIK: 0001843677 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13D